SNPs Assessed By Commercial DNA Tests May Only Account For Small Percentage Of Risk For Several Common Diseases, Review Study Suggests

Reuters (1/8, Rapaport) reports a study published in PLoS ONE challenges the value of commercial DNA tests that assess consumers for single-nucleotide polymorphisms (SNPs). In the study, “researchers analyzed data from almost 600 earlier studies that foun...